School of Pharmacy

Publications in the Biomolecular Science and Medicinal Chemistry Division

Publications

Content
KELLAM,B., WARD,PA.., RAHIM,A.S.A. and CHHABRA,S.R., 2005. Nα-Dmc protected amino acid aglycones: versatile hydrogenolysis stable acceptors for O-glycosylation Tetrahedron Letters. 46(10), 1703-1706

Content
SEDMAN, V.L., ALLEN, S., CHAN, W.C., KELLAM, B. and TENDLER S.J.B., 2005. Functionalizing human amylin (20-29) fibrils FEBS Journal. 272, 517-518

Content
ALI, BE, DE BANK, PA, KELLAM, B and SHAKESHEFF, KM, 2005. Controlled cell aggregation via cell-surface engineering International Journal of Experimental Pathology. 86(3), A21-A22

Content
SEDMAN, V.L., ALLEN, S., CHAN, W.C., DAVIES, M.C., ROBERTS, C.J., TENDLER, S.J.B. and WILLIAMS, P.M., 2005. Atomic force microscopy study of human amylin (20-29) fibrils Protein and Peptide Letters. 12(1), 79-83

Content
GARDINER, L., COYLE, B.J, CHAN, W.C and SOULTANAS, P., 2005. Discovery of antagonist peptides against bacterial helicase-primase interaction in B. stearothermophilus by reverse yeast three-hybrid. Chemistry & Biology. 12(5), 595-604

Content
SEDMAN, V.L., ALLEN, S., CHAN, W.C., KELLAM, B. and TENDLER S.J.B., 2005. Functionalizing human amylin (20-29) fibrils FEBS Journal. 272, 517-518

Content
SEVILLE, LUCY L, SHAH, NITA, WESTWELL, ANDREW D and CHAN, WENG C, 2005. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Current Cancer Drug Targets. 5(3), 159-70

Content
ZHELEVA, D.L., FISCHER, P.M., MCINNES, C., ANDREWS, M.J.I., CHAN, W.C. and ATKINSON, G.E., 2005. Cyclin binding peptides, and their use in drug screening assays WO 2005/040802 A3 05/06/2005 00:00:00

Content
BOURQUE, E, KOCIENSKI, PJ, STOCKS, M and YUEN, J, 2005. Synthesis of the c14-c28 fragment of tetronasin Synthesis-Stuttgart. 3219-3224

Content
STOCKS, MJ, BARBER, S, FORD, R, LEROUX, F, ST-GALLAY, S, TEAGUE, S and XUE, YF, 2005. Structure-driven htl: Design and synthesis of novel aminoindazole inhibitors of c-jun n-terminal kinase activity Bioorganic & Medicinal Chemistry Letters. 15(14), 3459-3462

Content
MUKHERJEE, A., WESTWELL, A.D., BRADSHAW, T.D., STEVENS, M.F.G., CARMICHAEL, J. and MARTIN, S.G., 2005. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study British Journal of Cancer. 92, 350-358

Content
BERRY, J.M., BRADSHAW, T.D., FICHTNER, I., REN, R., SCHWALBE, C.H., WELLS, G., CHEW, E.-H., STEVENS, M.F.G. and WESTWELL, A.D., 2005. Quinols as novel therapeutic agents. 2. 4-(1-arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents Journal of Medicinal Chemistry. 48(2), 639-644

Content
BRADSHAW,T.D., MORTIMER,C.G. and WESTWELL,A.D., 2005. Update to: the aryl hydrocarbon receptor in anticancer drug discovery: friend or foe? Medicinal Chemistry Reviews - Online. 2(2), 153-161

Content
PAPAGRIGORIOU, E., GINGRAS, A.R., BARSUKOV, I.L., BATE, N., FILLINGHAM, I.J., PATEL, B., FRANK, R., ZIEGLER, W.H., ROBERTS, G.C.K., CRITCHLEY, D.R. and EMSLEY, J., 2004. Activation of a vinculin-binding site in the talin rod involves rearrangement of a five-helix bundle EMBO Journal. 23(15), 2942-2951

Content
EMSLEY, JONAS, KNIGHT, C GRAHAM, FARNDALE, RICHARD W and BARNES, MICHAEL J, 2004. Structure of the integrin alpha2beta1-binding collagen peptide. Journal of Molecular Biology. 335(4), 1019-28
Displaying 661 to 675 of 914
Previous … 43 44 45 46 47 … Next

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit:
www.nottingham.ac.uk/enquiry